Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 2 , Pages 132-138 , February 2008

Agitation Treatment for Pediatric Emergency Patients

,Accepted 5 September 2007.

REFERENCES 

  1. American Academy of Child and Adolescent Psychiatry  . Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint . J Am Acad Child Adolesc Psychiatry . 2002;41(Suppl):4s–25s
  2. Dorfman DH . The use of physical and chemical restraints in the pediatric emergency department . Pediatr Emerg Care . 2000;16:355–360
  3. Fisher WA . Restraint and seclusion: a review of the literature . Am J Psychiatry . 1994;151:1584–1591
  4. Department of Health and Human Services and Centers for Medicare and Medicaid Services  . Medicare and Medicaid programs; hospital conditions of participation: patients' rights (final rule) . Fed Reg . 2006;71:71377–71428
  5. Dorfman DH , Mehta SD . Restraint use for psychiatric patients in the pediatric emergency department . Pediatr Emerg Care . 2006;22:7–12
  6. Department of Health and Human Services and Centers for Medicare and Medicaid Services  . State operations manual, appendix pp, section §483.13(a). 2006; 54-60 . www.cms.hhs.gov Accessed July 2007.
  7. Allen MH , Currier GW , Carpenter D , et al.   Introduction, methods, commentary and summary . J Psychiatr Pract . 2005;11(Suppl 1):5–25
  8. Dorfman D , Kastner B . The use of restraint for pediatric psychiatric patients in emergency departments . Pediatr Emerg Care . 2004;20:151–156
  9. Heyneman EK . The aggressive child . Child Adolesc Psychiatr Clin N Am . 2003;12:667–677
  10. Prager L . Child psychiatry in the emergency department . In:  Finberg L ,  Kleinman RE editor. Saunders Manual of Pediatric Practice . 2nd ed. Philadelphia: Saunders; 2002;p. 216–219
  11. Thomas LE , King RA . Child and adolescent psychiatric emergencies . In:  Lewis M editors. Child and Adolescent Psychiatry. A Comprehensive Textbook . 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2002;p. 1104–1110
  12. Connor DF , Steingard RJ , Cunningham JA , et al.   Proactive and reactive aggression in referred children and adolescents . Am J Orthopsychiatry . 2004;74:129–136
  13. Steiner H , Saxena K , Chang K . Psychopharmacologic strategies for the treatment of aggression in juveniles . CNS Spectr . 2003;8:298–308
  14. Pappadopulos E , Woolston S , Chait A , et al.   Pharmacotherapy of aggression in children and adolescents: efficacy and effect size . J Can Acad Child Adolesc Psychiatry . 2006;15:27–39
  15. Cohen J . Statistical Power Analysis for the Behavioral Sciences . 2nd ed. Hillsdale, NJ: Erlbaum; 1988;
  16. Lukens T , Wolf S , Edlow JA , et al.   Clinical policy: critical issues in the diagnosis and management of the adult psychiatric patients in the emergency department . Ann Emerg Med . 2006;47:79–99
  17. Currier GW , Medori R . Orally versus intramuscularly administered antipsychotic drugs in psychiatric emergencies . J Psychiatr Pract . 2006;12:30–40
  18. Aleman A , Kahn RS . Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials . Eur Neuropsychopharmacol . 2001;11:289–293
  19. Yildiz A , Sachs GS , Turgay A . Pharmacological management of agitation in emergency settings . Emerg Med J . 2003;20:339–346
  20. Currier GW , Trenton A . Pharmacological treatment of psychotic agitation . CNS Drugs . 2002;16:219–228
  21. Yildiz A , Turgay A , Meneske A , et al.   Observational data on the antiagitation effect of risperidone tablets in emergency settings: a preliminary report . Int J Psychiatr Clin Pract . 2003;7:217–221
  22. Lejeune J , Larmo I , Chrzanowski W , et al.   Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis . Int Clin Psychopharmacol . 2004;19:259–269
  23. Currier GW , Simpson GM . Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam. for treatment of psychotic agitation . J Clin Psychiatry . 2001;62:153–157
  24. Currier GW , Chou JC , Feifel D , et al.   Acute treatment of psychotic agitation: randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam . J Clin Psychiatry . 2004;65:386–394
  25. van Schaick EA , Lechat P , Remmerie BM , et al.   Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers . Clin Ther . 2003;25:1687–1699
  26. Physicians' Desk Reference . 60th ed. New York: Thomson Healthcare; 2006;
  27. Currier GW , Trenton AJ , Walsh PG , et al.   A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting . J Psychiatr Pract . 2006;12:223–228
  28. Zimbroff DL , Allen MH , Battaglia J , et al.   Best clinical practice with ziprasidone IM: update after 2 years of experience . CNS Spectr . 2005;10:1–15
  29. Hazaray E , Ehret J , Posey DJ , et al.   Intramuscular ziprasidone for acute agitation in adolescents . J Child Adolesc Psychopharmacol . 2004;14:464–470
  30. Staller JA . Intramuscular ziprasidone in youth: a retrospective chart review . J Child Adolesc Psychopharmacol . 2004;14:590–592
  31. Khan SS , Mican LM . A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents . J Child Adolesc Psychopharmacol . 2006;16:671–677
  32. Wermeling DPH , Miller JL , Archer SM , et al.   Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous and intramuscular administration . J Clin Pharmacol . 2001;41:1225–1231
  33. Micromedex Drugdex, 2007 . www.thomsonhc.com Accessed May 25, 2007.

 Editorships of Mina K. Dulcan, M.D., and Michael S. Jellinek, M.D. Dr. Jellinek served as Associate Editor under Dr. Dulcan and oversaw the Clinical Perspectives column.Case scenarios described in this article are composites created by the authors and do not refer to any specific patient or family.Disclosure: The authors report no conflicts of interest.

PII: S0890-8567(09)62283-8

doi: 10.1097/chi.0b013e31815d95fd

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 2 , Pages 132-138 , February 2008

Article Tools

* Image Usage & Resolution